Out here to support my boy @trinity2pointO dooks. Super excited to meet my boy. It'll be the first time I meet him and we've known each other for over 4 years at this point it seems like. If anybody's going to be at the convention, be sure to watch out for the guy with the Kimera hat on cause thats me! Excited to meet many people on here @Dustin_Newman and @labs_vanguard. If I'm missing someone tag yourself and I'll be on the lookout for you Friday and Saturday

Kimera did not get me hooked on a compound list. They got me hooked on the paperwork. @kimerachems is the reason I stopped treating a COA like a gold star sticker and started treating it like part of an experiment. Most of this industry sells you a name. A good vendor sells you a traceable lot. “We test everything.” Cool. Where is the chromatogram? What method was used? Which batch was tested? Does that batch match the bottle in my hand? Who submitted the sample? What exactly was measured? A logo and a purity number are not traceability. What changed my thinking was not hearing, “We use HPLC.” Everybody says that. It was learning to look at the details and understand what each test can and cannot establish. Identity is not purity. HPLC can separate components and estimate how much of the detected material belongs to the main peak under that specific method. Retention time may support identity when it is compared with a legitimate reference standard, but a peak appearing where you expected does not independently prove that the material is what the label claims. Mass spectrometry asks whether the measured mass matches the expected mass. NMR looks at the underlying structure and molecular environment. Elemental analysis checks whether the measured elemental composition makes sense. None of these methods is magic by itself. They answer different questions, which is exactly why multiple methods are more useful than one impressive-looking number. The type of material matters too. A defined molecule and a complex hydrolysate should not be tested or described the same way. A sharp peak may make sense for a single purified molecule. It does not make sense to tell that same one-peak story about a mixture containing many different fragments. If the material is a hydrolysate, I want to see a molecular-weight distribution, peptide map, and amino-acid profile. Those are three different views of the sample. The amino-acid profile tells you which building blocks were present after everything was broken down. The peptide map shows how those building blocks were still connected. The molecular-weight distribution shows how much falls within the expected size ranges. One giant “purity” peak for a complex mixture is not impressive. It is the wrong test trying to answer the wrong question. Methods are not interchangeable between labs either. You can send the same sample to two laboratories and get two different purity values without either laboratory necessarily committing fraud. Columns differ. Mobile phases differ. Wavelengths differ. Sample preparation differs. Integration rules differ. Reference standards and calibration methods differ. One lab may report area percentage from a messy baseline. Another may perform a quantitative assay using a qualified reference standard and calibration curve. Those numbers may look similar on a PDF while meaning very different things. “98.7% pure” without the method is a caption. “98.7% by RP-HPLC using a defined column, wavelength, reference standard, and documented integration method” is an actual result you can examine and challenge. Endotoxin is also not a purity percentage. A sample can produce a beautiful chromatogram and still have an unacceptable endotoxin result. HPLC does not replace endotoxin testing. It also does not answer every question about residual solvents, heavy metals, microbial contamination, residual proteins, moisture, or other unwanted material. Those require their own methods and their own pages. People tend to skip those pages because they are not as easy to market as a giant “99% PURE” graphic. But those boring pages are often where the most important information lives. A COA should not shut down questions. It should give you enough information to start asking better ones.

The FLGR-242 vs MID-35 debate is becoming too emotional, and I think we’re losing sight of what experimental biohacking is actually about. There are legitimate reasons to criticize the way FLGR-242 is being marketed. BioLongevity Labs, and especially Jay Campbell, often communicate with a level of certainty that feels disproportionate to the available evidence. When strong efficacy claims come from someone who also owns the company selling the compound, skepticism is understandable. But I also disagree with the opposite extreme: “No human data = nobody should experiment with it.” That has never been how biohacking works. Biohackers routinely explore compounds with only animal data. Sometimes only cellular data. Occasionally little more than a plausible mechanism. That doesn’t make them safe or effective. It simply means the real question is “How much evidence exists before the first N=1 begins, and how much uncertainty are we accepting?” That is where MID-35 and FLGR-242 differ. MID-35 has a defined molecule, published mechanistic work, binding data, animal studies, observed hypertrophy and documented limitations. FLGR-242 has a plausible engineering concept, supporting literature around parts of its design, albumin-binding technology and manufacturer claims. Both eventually reach the same cliff: We do not know what either does in humans. But they did not reach that cliff with the same amount of evidence. That matters. It changes uncertainty. And probably risk. What concerns me more than either compound is that the current vendor drama is distracting us from generating useful N=1 data. Instead of improving experimental methodology, we are arguing about personalities. The affiliate ecosystem makes this even worse. If someone says: “FLGR transformed my physique” while also changing testosterone, GH, Anavar, GLP-1s, calories, training, and receiving free product or affiliate revenue, that observation becomes very difficult to interpret. That doesn’t mean they are lying. Conflict of interest does not invalidate an observation. It changes how much weight we should assign to it. The problem isn’t anecdotal evidence either. Early biohacking is largely built on anecdotal evidence. The problem is LOW-quality anecdotal evidence presented with HIGH confidence. There is a huge difference between: “I took this and got huge.” and: “Here was my baseline. Here was my training, diet and other compounds. Nothing else changed. Here are objective measurements, side effects, product testing and what happened after stopping. I have no financial relationship with the vendor.” Both are N=1. They are not remotely equivalent evidence. So remove BioLongevity. Remove Kimera. Remove Jay Campbell. Remove affiliates, discount codes and personalities. What remains are two experimental molecules. MID-35 has substantially more preclinical evidence. FLGR-242 is considerably more speculative. Both have enormous human uncertainty. The intellectually honest position is neither “MID-35 is proven.” nor “FLGR is bullshit because there are no human trials.” It is epistemic humility. Treat MID-35 as an experimental compound with meaningful preclinical evidence. Treat FLGR-242 as an experimental compound supported mostly by mechanistic plausibility, with substantially greater uncertainty. Then collect better data. In fact, the lack of FLGR data makes independent N=1 observations MORE valuable. But it should also make early adopters MORE cautious, because they may effectively be investigating efficacy, pharmacokinetics and toxicity at the same time. That should create humility. Not certainty. If you truly believe you developed something extraordinary, the strongest scientific posture is “Here is what we believe. Here is why. Here is what we know. Here is what we don’t know. Now let’s find out.” Uncertainty is not the enemy of biohacking. Pretending uncertainty doesn’t exist is.

Kimera weekend labor day sale: 20% off with code nelly kimerachems.co/?coupon=nelly… research use only. I earn a commission through this link and a quick note on Kimera in general: